442 related articles for article (PubMed ID: 9972981)
1. Favorable response to intravenous methylprednisolone and cyclophosphamide in children with severe neuropsychiatric lupus.
Baca V; Lavalle C; García R; Catalán T; Sauceda JM; Sánchez G; Martínez I; Ramírez ML; Márquez LM; Rojas JC
J Rheumatol; 1999 Feb; 26(2):432-9. PubMed ID: 9972981
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of acute systemic lupus erythematosus with intravenous infusions of cyclophosphamide. Value and limitations].
De Bandt M; Goycochea MV; Meyer O; Delahousse M; Palazzo E; M'Bappé P; Kahn MF
Ann Med Interne (Paris); 1994; 145(2):75-87. PubMed ID: 8024184
[TBL] [Abstract][Full Text] [Related]
3. Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus.
Neuwelt CM; Lacks S; Kaye BR; Ellman JB; Borenstein DG
Am J Med; 1995 Jan; 98(1):32-41. PubMed ID: 7825616
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children.
Tangnararatchakit K; Tapaneya-Olarn C; Tapaneya-Olarn W
J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S104-10. PubMed ID: 10730528
[TBL] [Abstract][Full Text] [Related]
5. Trends of anticardiolipin antibodies after low-dose methylprednisolone and cyclophosphamide treatment of systemic lupus erythematosus.
Lavalle-Graef A; Villegas-Acosta L; Lavalle C
Arch Med Res; 2004; 35(5):421-7. PubMed ID: 15610913
[TBL] [Abstract][Full Text] [Related]
6. Acute transverse myelopathy in systemic lupus erythematosus: clinical presentation, treatment, and outcome.
Mok CC; Lau CS; Chan EY; Wong RW
J Rheumatol; 1998 Mar; 25(3):467-73. PubMed ID: 9517765
[TBL] [Abstract][Full Text] [Related]
7. Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy.
Roccatello D; Sciascia S; Rossi D; Alpa M; Naretto C; Baldovino S; Menegatti E; La Grotta R; Modena V
Nephrol Dial Transplant; 2011 Dec; 26(12):3987-92. PubMed ID: 21385860
[TBL] [Abstract][Full Text] [Related]
8. [Effects of therapies on childhood systemic lupus erythematosus].
Kurosawa R; Umezawa R; Kobayashi Y; Nakajima S; Miyamae T; Ito S; Imagawa T; Katakura S; Mori M; Aihara Y; Yokota S
Ryumachi; 2003 Oct; 43(4):632-7. PubMed ID: 14598654
[TBL] [Abstract][Full Text] [Related]
9. [Methylprednisolone and cyclophosphamide pulse therapy of severe systemic lupus erythematosus in children].
Hu J; Li CW; Zhang X; Pi SH; Zhao JS; Chen XY; Liu Y
Zhonghua Er Ke Za Zhi; 2003 Jun; 41(6):430-4. PubMed ID: 14748998
[TBL] [Abstract][Full Text] [Related]
10. Intravenous cyclophosphamide pulse therapy in Japanese children with systemic lupus erythematosus.
Igarashi T; Igarashi T; Shimizu A; Itoh Y
J Nippon Med Sch; 2013; 80(5):396-400. PubMed ID: 24189359
[TBL] [Abstract][Full Text] [Related]
11. Risk of ovarian failure and fertility after intravenous cyclophosphamide. A study in 84 patients.
Huong DL; Amoura Z; Duhaut P; Sbai A; Costedoat N; Wechsler B; Piette JC
J Rheumatol; 2002 Dec; 29(12):2571-6. PubMed ID: 12465154
[TBL] [Abstract][Full Text] [Related]
12. Transverse myelitis affecting more than 4 spinal segments associated with systemic lupus erythematosus: clinical, immunological, and radiological characteristics of 22 patients.
Espinosa G; Mendizábal A; Mínguez S; Ramo-Tello C; Capellades J; Olivé A; Cervera R
Semin Arthritis Rheum; 2010 Feb; 39(4):246-56. PubMed ID: 19022478
[TBL] [Abstract][Full Text] [Related]
13. Systemic lupus erythematosus in Thai children: clinicopathologic findings and outcome in 82 patients.
Pattaragarn A; Sumboonnanonda A; Parichatikanond P; Supavekin S; Suntornpoch V; Vongjirad A
J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S232-41. PubMed ID: 16856445
[TBL] [Abstract][Full Text] [Related]
14. Fulminant onset of cerebral immunocomplex vasculitis as first manifestation of neuropsychiatric systemic lupus erythematosus (NPSLE).
Rizos T; Siegelin M; Hähnel S; Storch-Hagenlocher B; Hug A
Lupus; 2009 Apr; 18(4):361-3. PubMed ID: 19276305
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal involvement of the spinal cord in a patient with lupus related transverse myelitis.
Deodhar AA; Hochenedel T; Bennett RM
J Rheumatol; 1999 Feb; 26(2):446-9. PubMed ID: 9972984
[TBL] [Abstract][Full Text] [Related]
16. Reversible parkinsonian syndrome in systemic and brain vasculitis.
Fabiani G; Teive HA; Germiniani FM; Sá DS; Werneck LC
Mov Disord; 2002 May; 17(3):601-4. PubMed ID: 12112215
[TBL] [Abstract][Full Text] [Related]
17. Intravenous cyclophosphamide for lupus nephritis in Thai children.
Vachvanichsanong P; Dissaneewate P; Winn T
Scand J Rheumatol; 2004; 33(5):339-42. PubMed ID: 15513684
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of transverse myelitis in a child with systemic lupus erythematosus.
Baca V; Sanchez-Vaca G; Martínez-Muñiz I; Ramírez-Lacayo M; Lavalle C
Neuropediatrics; 1996 Feb; 27(1):42-4. PubMed ID: 8677025
[TBL] [Abstract][Full Text] [Related]
19. High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus.
Petri M; Jones RJ; Brodsky RA
Arthritis Rheum; 2003 Jan; 48(1):166-73. PubMed ID: 12528116
[TBL] [Abstract][Full Text] [Related]
20. Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus.
Mok CC; Lau CS; Wong RW
J Rheumatol; 2001 Apr; 28(4):766-71. PubMed ID: 11327248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
